Antony is yet to score or assist this season (Photo: Getty)
Paul Scholes says he would like to see Anthony Martial starting more for Manchester United in the place of Antony.
His comments came ahead of United’s crucial Champions League match at Galatasaray on Wednesday evening.
Erik ten Hag made four changes to his side from the one that beat Everton 3-0 last Sunday, with Antony coming in to replace the suspended Marcus Rashford.
Despite scoring and assisting at Goodison Park, Martial was dropped to the bench in favour of Rasmus Hojlund who has recovered from injury.
They’re not changes that United legend Scholes agrees with however, believing that the French forward is better suited to how the Red Devils play than the Brazil winger.
‘I would have liked to have seen Martial play,’ the former England midfielder told TNT Sports.
‘He’s clinical, United have to play on the counter-attack. With the type of team they’ve got they can’t control games, so they have to rely on their forward players.
Anthony Martial was benched for Man Utd vs Galatasaray (Photo: Getty)
‘Antony has not been great, he’s not played a lot, I’m not sure where he’ll be at fitness-wise. We just had the international break where he won’t have played either.
‘I would have liked to have seen Martial come into that front three alongside [Alejandro] Garnacho and Hojlund.’
It should be noted that neither forward is having a particularly good season, though Martial has at least scored two and assisted two in 480 minutes of game time so far, compared to Antony who is yet to provide a single contribution in 650 minutes of action.
More: Trending
Explaining the decision to bring Hojlund in for Martial, Ten Hag said: ‘We are happy Anthony Martial is fit over a long period. We want to keep him fit, he will contribute this season.
‘Rasmus’ speed is a huge weapon. We want to use that.’
MORE : Jurgen Klopp gives worrying injury update on key Liverpool duo Alisson Becker and Diogo Jota
For more stories like this, check our sport page.
Follow Metro Sport for the latest news on Facebook, Twitter and Instagram.
‘He’s clinical.’
